On November 16, the Office of Inspector General for the U.S. Department of Health and Human Services (OIG) published Advisory Opinion 21-16, approving an arrangement under which a pharmaceutical ...
Government revises new arrangement after considering public opinion and stakeholder feedback, with charges kicking in from fifth week after death.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback